跳至主要内容
临床试验/CTRI/2022/02/040338
CTRI/2022/02/040338已完成未知

Evaluation of dermatological safety of test products by primary irritation patch test on healthy human volunteers of varied skin types

Arbro pharmaceutical Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Healthy male and female subjects in the age
  • group of 18-55 years(both age inclusive)
  • 2. Subject is having valid proof of
  • identity and age
  • 3. Subjects with skin phototype III to V
  • 4.Subject is having apparently healthy skin on
  • 5.Subject representing normal, oily, dry and
  • combination skin type in nearly equal ratio
  • 6.Subject willing to give a voluntary written
  • informed consent
  • 7.Subject willing to maintain the test patches
  • in designated positions for 24 Hours
  • 8.Subject willing to come for regular follow up
  • 9.Subject ready to follow instructions during the
  • study period
  • 10.Subject without any open wounds, cuts,
  • abrasions, irritation symptoms

排除标准

  • 1. Subjects with Known hypersensitivity to any of
  • the study products or constituents
  • 2. Subjects having any significant pathology in
  • the test area
  • 3. Subjects with any kind of skin allergy,
  • antecedents or cutaneous disease which may
  • influence the study results
  • 4. Subjects having topical or systemic treatment
  • in last month prior to participation in the
  • study and during the study that could interfere
  • with the study treatments/ assessments
  • 5. Athletes and subjects with history of excessive
  • 6. Subject is Pregnant or Lactating
  • 7. Subject with any significant medical condition
  • that would interfere with the participation in
  • 8. Subjects participated in any other cosmetic or
  • therapeutic trial or in a similar investigation
  • 9. Subject is having Scars, excessive terminal
  • hair or tattoo on the studied area

研究者

发起方
Arbro pharmaceutical Pvt Ltd

相似试验